B

BioMedPartners

7 employees

BioMedPartners is one of the leading European venture capital firms.

Investor insights

Sectors invested in

Biotechnology43
Health Care36
Therapeutics19
Medical Device17
Pharmaceutical13
Medical12
Health Diagnostics8
Neuroscience6
Manufacturing6
Oncology6
Biopharma5
Life Science5
Drug Discovery5
Drug Development5
Clinical Trials4
Neurosurgery4
Deep Brain Stimulation4
Medical Device Development4
Immuno-Oncology4
Cancer Drug Resistance3

Funding rounds participated in

$15M sweet spot round size

Most of their 71 investments are in rounds between $9.2M and $26M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Financial Services
Venture Capital

Date founded

2002

Investments made

T

TOLREMO therapeutics AG raised $3.8M on September 20, 2023

Investors: BioMedPartners

U

Undisclosed raised $47M on September 16, 2022

Investors: Andera Partners, Crédit Mutuel Innovation, Karista, 415 CAPITAL, GO CAPITAL, Wellington Partners and BioMedPartners

T

Tubulis GmbH raised $63M on May 3, 2022

Investors: Evotec, Andera Partners, OCCIDENT, Bayern Kapital GmbH, High-Tech Gründerfonds, coparion, Seventure Partners, FundPlus and BioMedPartners

P

Precirix raised $88M on March 16, 2022

Investors: Gimv, Pontifax Venture Capital, Inkef, HealthCap, Novo Holdings, V-Bio Ventures, Forbion and BioMedPartners

S

Scenic Biotech raised $31M on March 10, 2022

Investors: Oxford Sciences Innovation, Eir Ventures, BGV (BioGeneration Ventures), Inkef and BioMedPartners

C

Cardior Pharmaceuticals raised $75M on August 25, 2021

Investors: coparion, Sunstone Partners, Inkef, EQT Life Sciences, Hadean Ventures, Bristol-Myers Squibb, UK, FundPlus and BioMedPartners

T

Topas Therapeutics GmbH raised $21M on July 29, 2021

Investors: Gimv, Evotec, EMBL Ventures, Epidarex Capital, Vesalius Biocapital and BioMedPartners

A

Alentis Therapeutics raised $67M on June 15, 2021

Investors: Pureos Bioventures, Kinled Holding Ltd, High-Tech Gründerfonds, Morningside Venture Capital 晨兴资本, JEITO and BioMedPartners

N

Noema Pharma raised $60M on December 1, 2020

Investors: The Invus Group, Sofinnova Partners, Polaris Partners, Gilde Healthcare and BioMedPartners

T

Topas Therapeutics GmbH raised $26M on October 19, 2020

Investors: Gimv, Vesalius Biocapital, Epidarex Capital and BioMedPartners

FAQ